The US Food & Drug Administration is triaging COVID-19 treatment protocols and other coronavirus-related inquiries coming into the agency using a team led by the Division of Anti-Infectives as part of an unprecedented reallocation of personnel across the agency in response to the pandemic, Office of New Drugs Director Peter Stein said in an interview with the Pink Sheet.
The group, known as the “COVID Scientific Technical Triage Team,” is the forward-facing part of the Coronavirus Treatment Acceleration Program,...








